Maetzel Andreas
Insider CIK 1576103 · CRTX VP, Clinical and Regulatory · KALV Senior Vice President, Medical
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-05-26 | 2021-05-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-04-29 | 2021-04-29 | 14,662 | — | $0 | 6,038 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-04-29 | 2021-04-29 | 13,368 | — | $0 | 7,332 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-04-29 | 2021-04-29 | 12,856 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-04-29 | 2021-04-29 | 12,856 | $7.91 | $101.7K | 12,856 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-04-29 | 2021-04-29 | 14,662 | $8.21 | $120.4K | 27,518 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-04-29 | 2021-04-29 | 13,368 | $16.08 | $215.0K | 40,886 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-29 | 2021-04-29 | 40,886 | $25.04 | $1.02M | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-04-28 | 2021-04-29 | 36,127 | — | $0 | 12,856 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-04-28 | 2021-04-29 | 36,127 | $7.91 | $285.8K | 36,127 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-28 | 2021-04-29 | 10,620 | $25.50 | $270.8K | 25,507 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-28 | 2021-04-29 | 15,000 | $25.25 | $378.8K | 10,507 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-28 | 2021-04-29 | 10,000 | $25.54 | $255.4K | 507 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-28 | 2021-04-29 | 507 | $25.65 | $13.0K | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-04-27 | 2021-04-29 | 11,017 | — | $0 | 48,983 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-04-27 | 2021-04-29 | 11,017 | $7.91 | $87.1K | 11,017 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-27 | 2021-04-29 | 11,017 | $25.79 | $284.1K | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-12-16 | 2020-12-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-05-15 | 2019-05-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-04-05 | 2019-04-09 | 5,000 | — | $0 | 60,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-05 | 2019-04-09 | 5,000 | $30.00 | $150.0K | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-04-05 | 2019-04-09 | 5,000 | $7.91 | $39.5K | 5,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-09-18 | 2018-09-20 | 20,700 | — | $0 | 20,700 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-06-04 | 2018-06-06 | 20,700 | — | $0 | 20,700 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-03-08 | 2017-03-09 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 25,000 | $1.10 | $27.5K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer | 2014-02-03 | 2014-02-04 | 25,000 | $9.50 | $237.5K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award deriv | 2013-05-06 | 2013-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award | 2013-05-06 | 2013-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |